IL1B and COVID-19: Furthermore, autoimmune diseases can be triggered by COVID-19 in genetically predisposed patients, following the activation of an aberrant immune response by the cytokine cascade (TNF-α, IL-6, IL-1β, IL-17, and IL-18) induced by SARS-CoV-2 [9] (Table 3).